Results 221 to 230 of about 24,136 (236)

MEN1 mutations mediate clinical resistance to menin inhibition

Nature, 2023
Daniela Vanessa Wenge, Homa Rahnamoun, Richard M Stone   +2 more
exaly  

Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)

Journal of Clinical Endocrinology and Metabolism, 2012
Rajesh V Thakker, Paul J Newey, John P Bilezikian   +2 more
exaly  

Current and emerging therapies for PNETs in patients with or without MEN1

Nature Reviews Endocrinology, 2018
Morten Frost, Kate E Lines, Rajesh V Thakker   +2 more
exaly  

ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup

Nature Communications, 2018
Saurabh V Laddha, Peter W Lewis, Timothy A Chan   +2 more
exaly  

Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)

Molecular and Cellular Endocrinology, 2014
Rajesh V Thakker
exaly  

Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene

Human Mutation, 2008
Manuel C. Lemos, Rajesh V Thakker
exaly  

Challenges and controversies in management of pancreatic neuroendocrine tumours in patients with MEN1

Lancet Diabetes and Endocrinology,the, 2015
Christopher J Yates, Paul J Newey, Rajesh V Thakker   +2 more
exaly  

Targeting β-catenin signaling for therapeutic intervention in MEN1-deficient pancreatic neuroendocrine tumours

Nature Communications, 2014
Yanan Cao, Yutong Su, Yanli Li
exaly  

MEN1 Disease Occurring Before 21 Years Old: A 160-Patient Cohort Study From the Groupe d'étude des Tumeurs Endocrines

Journal of Clinical Endocrinology and Metabolism, 2015
Bruno Vergès
exaly  

Multiple endocrine neoplasia type 1 (MEN1)

Best Practice and Research in Clinical Endocrinology and Metabolism, 2010
Rajesh V Thakker
exaly